Big Buttons

• HIPAA, schmipaa — Lilly is at it again

  Now Eli Lilly is trying to "convince" people who have used compounded versions of tirzepatide to share their confidential medical records with the company. read more →

• Settlement reached in Evexias suit against FDA

  A settlement has been reached in a lawsuit brought by Evexias et al against FDA over the agency's 2023 addition of a number of substances to Category 2 of the 503A bulks list. read more →

• Rochefort receives Malmberg Award

  David Rochefort of Revelation Pharma is this year's recipient of the George and Lucy Malmberg Compounding Advocacy Champion award — APC’s highest honor. read more →

• For they’re jolly good Fellows*

  This year’s CCH featured the induction of seven new APC fellows. read more →

• Be fruitful and multiply … our messaging, that is

  Even if you didn't attend Compounders on Capitol Hill, you can multiply the effect of those Hill visits. read more →

• APC supports upcoming DEA guidance on constructive transfer

  Some good news: DEA is set to issue much-needed new guidance on constructive transfer. read more →

• 503Bs: FDA has questions, and so do we (do you?)

  FDA has requested comments on the challenges and opportunities faced by compounding outsourcing facilities. read more →

• Meet our compounding defenders, guardians and champions (Oh my!)

  Here’s a big thank you to our Package Deal investors.  read more →

More News

Well check this out: A news story about compounded GLP-1s that’s actually accurate, sans all the usual hand-wringing and fear-mongering. It aligns pretty well with the message APC has been shouting from the rooftops, too. Coincidence? With all the effort we’ve put into that message, we think not, especially considering it quotes CEO Scott Brunner several times. Here’s a snippet:

Compounding pharmacies exist to help patients whose needs aren’t met by existing approved drugs. The compounded drugs are not generics, nor do they go through the Food and Drug Administration’s approval process. Instead, compounding pharmacists tailor drugs for individual patients who need them and are mostly regulated on the state level by boards of pharmacy.

For patients who want a quick primer on how they can be sure their compounded meds are safe, APC’s Scott Brunner has a video you should check out — and share far and wide.